|
|
|
|
IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c+ cell populations during visceral leishmaniasis
|
|
|
|
|
|
|
|
نویسنده
|
owens b.m.j. ,beattie l. ,moore j.w.j. ,brown n. ,mann j.l. ,dalton j.e. ,maroof a. ,kaye p.m.
|
|
منبع
|
plos pathogens - 2012 - دوره : 8 - شماره : 7 - صفحه:20
|
|
چکیده
|
Il-10 is a critical regulatory cytokine involved in the pathogenesis of visceral leishmaniasis caused by leishmania donovani and clinical and experimental data indicate that disease progression is associated with expanded numbers of cd4+ ifnγ+ t cells committed to il-10 production. here,combining conditional cell-specific depletion with adoptive transfer,we demonstrate that only conventional cd11chi dcs that produce both il-10 and il-27 are capable of inducing il-10-producing th1 cells in vivo. in contrast,cd11chi as well as cd11cint/lo cells isolated from infected mice were capable of reversing the host protective effect of diphtheria toxin-mediated cd11c+ cell depletion. this was reflected by increased splenomegaly,inhibition of no production and increased parasite burden. thus during chronic infection,multiple cd11c+ cell populations can actively suppress host resistance and enhance immunopathology,through mechanisms that do not necessarily involve il-10-producing th1 cells. © 2012 owens et al.
|
|
|
|
|
آدرس
|
centre for immunology and infection,hull york medical school and department of biology,university of york,york,united kingdom,translational gastroenterology unit,experimental medicine division,nuffield department of medicine,university of oxford,oxford, United Kingdom, centre for immunology and infection,hull york medical school and department of biology,university of york,york, United Kingdom, centre for immunology and infection,hull york medical school and department of biology,university of york,york, United Kingdom, centre for immunology and infection,hull york medical school and department of biology,university of york,york, United Kingdom, centre for immunology and infection,hull york medical school and department of biology,university of york,york, United Kingdom, centre for immunology and infection,hull york medical school and department of biology,university of york,york, United Kingdom, centre for immunology and infection,hull york medical school and department of biology,university of york,york,united kingdom,ucb pharma,slough,berkshire, United Kingdom, centre for immunology and infection,hull york medical school and department of biology,university of york,york, United Kingdom
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|